Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Flexner

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Archives of Biochemistry and Biophysics|December 1, 1995
Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adductS J Chavan, W G Bornmann, C Flexner, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2000
Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitorsR R Speck, C Flexner, C J Tian, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
Comparison of the effects of 3'-azidothymidine with those of neutralizing antibodies on simian immunodeficiency virus infection in macrophagesM F McEntee, C Flexner, H Farzadegan, et al.
Journal of Virology|April 3, 1998
Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assemblyX F Yu, L Dawson, C J Tian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1996
Drug interactions in patients infected with human immunodeficiency virusS C Piscitelli, C Flexner, J R Minor, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Balancing justice and autonomy in clinical research with healthy volunteersN E Kass, R Myers, E J Fuchs, et al.
JAMA|May 1, 1991
Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudineR D Moore, H Kessler, D D Richman, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjectsC W Hendrix, C Flexner, J Szebeni, et al.
Nature|September 15, 1988
Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigenC Flexner, B R Murphy, J F Rooney, et al.
Clinical Pharmacology and Therapeutics|January 22, 2010
Payment to healthy volunteers in clinical research: the research subject's perspectiveM J Czarny, N E Kass, C Flexner, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Archives of Biochemistry and Biophysics|December 1, 1995
Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adductS J Chavan, W G Bornmann, C Flexner, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2000
Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitorsR R Speck, C Flexner, C J Tian, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
Comparison of the effects of 3'-azidothymidine with those of neutralizing antibodies on simian immunodeficiency virus infection in macrophagesM F McEntee, C Flexner, H Farzadegan, et al.
Journal of Virology|April 3, 1998
Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assemblyX F Yu, L Dawson, C J Tian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1996
Drug interactions in patients infected with human immunodeficiency virusS C Piscitelli, C Flexner, J R Minor, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Balancing justice and autonomy in clinical research with healthy volunteersN E Kass, R Myers, E J Fuchs, et al.
JAMA|May 1, 1991
Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudineR D Moore, H Kessler, D D Richman, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjectsC W Hendrix, C Flexner, J Szebeni, et al.
Nature|September 15, 1988
Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigenC Flexner, B R Murphy, J F Rooney, et al.
Clinical Pharmacology and Therapeutics|January 22, 2010
Payment to healthy volunteers in clinical research: the research subject's perspectiveM J Czarny, N E Kass, C Flexner, et al.
Pageof 7